Corcept Therapeutics Incorporated announced the appointment of Monica Tellado as President, Emerging Markets. She will report to Joseph K. Belanoff, MD, Corcepts Chief Executive Officer, and join the company?s Executive Team. Ms. Tellados prior role was at Heartflow, where she served as Chief Financial Officer.

Before joining Heartflow, Ms. Tellado spent 19 years in ascending leadership roles at Gilead Sciences, including Senior Vice President of Finance and Investor Relations; Vice President of Sales and Marketing for the companys Liver Disease Business Unit; and Vice President of Commercial Operations, where she led efforts to launch products across HIV, liver diseases, cardiopulmonary diseases, and oncology. At Corcept, Ms. Tellado will serve as the global commercial lead for therapeutics in metabolism and neurology. She will also oversee pipeline and portfolio planning activities across the company?s other therapeutic areas.